Publicacions en què col·labora amb FRANCISCO JAVIER SALMERÓN ESCOBAR (62)

2020

  1. Seroprevalence and epidemiology of hepatitis B and C viruses in pregnant women in Spain. Risk factors for vertical transmission

    PLoS ONE, Vol. 15, Núm. 5

2017

  1. AA-NAT, MT1 and MT2 correlates with cancer stem-like cell markers in colorectal cancer: Study of the influence of stage and p53 status of tumors

    International Journal of Molecular Sciences, Vol. 18, Núm. 6

  2. Expression and single nucleotide polymorphism of poly (ADP-ribose) polymerase-1 in gastrointestinal tumours: clinical involvement

    Current Medicinal Chemistry, Vol. 24, Núm. 20, pp. 2156-2173

  3. Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment

    World Journal of Gastroenterology, Vol. 23, Núm. 25, pp. 4538-4547

  4. Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children

    PLoS ONE, Vol. 12, Núm. 2

  5. The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Erratum: High-resolution hepatitis c virus subtyping using ns5b deep sequencing and phylogeny, an alternative to current methods (Journal of Clinical Microbiology (2015) 53:1 (219-226))

    Journal of Clinical Microbiology

  2. Hepatitis C durante la gestación, transmisión vertical y nuevas posibilidades de tratamiento

    Medicina Clinica, Vol. 147, Núm. 11, pp. 499-505

2015

  1. Hepatotoxicity from the consumption of herbalist products by a paediatric population

    Nutricion Hospitalaria, Vol. 32, Núm. 2, pp. 652-655

  2. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

    Journal of Clinical Microbiology, Vol. 53, Núm. 1, pp. 219-226

  3. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles

    Liver International, Vol. 35, Núm. 4, pp. 1430-1441

2014

  1. Melatonin reduces endothelin-1 expression and secretion in colon cancer cells through the inactivation of FoxO-1 and NF-κβ

    Journal of Pineal Research, Vol. 56, Núm. 4, pp. 415-426

2013

  1. Functionalized magnetic nanoparticles as vehicles for the delivery of the antitumor drug gemcitabine to tumor cells. Physicochemical in vitro evaluation

    Materials Science and Engineering C, Vol. 33, Núm. 3, pp. 1183-1192

  2. Hepatotoxicidad por fármacos o productos naturales en niños

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 78, Núm. 4, pp. 248-259

  3. Importance of IL-10 and IL-6 during chronic hepatitis c genotype-1 treatment and their relation with IL28B

    Cytokine, Vol. 61, Núm. 2, pp. 595-601

  4. Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer

    Molecular Carcinogenesis, Vol. 51, Núm. 8, pp. 608-618

  2. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients

    Histology and Histopathology, Vol. 27, Núm. 4, pp. 459-466

  3. Plasma Ribavirin trough concentrations during treatment of chronic hepatitis C in genotype-1 patients

    Journal of Clinical Gastroenterology, Vol. 46, Núm. 4, pp. 328-333

2011

  1. Factors associated with hepatic steatosis in obese children and adolescents

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 53, Núm. 2, pp. 196-201